Taiwan says deal to buy BioNTech vaccine on hold, cites potential pressure from China

block

Reuters :
Taiwan Health Minister Chen Shih-chung said officials were on the verge of announcing the deal in December when BioNTech pulled the plug.
While he did not directly say China was to blame, Chen implied there was a political dimension to the decision and that he had been worried about “outside forces intervening”, hence his caution in discussing the planned deal publicly.
“Certain people don’t want Taiwan to be too happy,” he added, without elaborating, in a radio interview.
China, which claims Taiwan as its own territory, has repeatedly sparred with the island over the coronavirus pandemic.
Taiwan has been angered by China’s assertion only it can speak for the island on the international stage about the subject, while Taiwan has accused China of lack of transparency.
BioNTech signed a deal with Chinese firm Shanghai Fosun Pharmaceutical Group Co Ltd to exclusively develop and commercialise Covid-19 vaccine products developed by using BioNTech’s mRNA technology in mainland China, Hong Kong, Macau and Taiwan.
In return it agreed to pay up to $85 million in licencing fees and invest $50 million for a stake in the German firm.
BioNTech’s development and distribution partner for the rest of the world is US firm Pfizer Inc.
Chen said BioNTech had not asked them to speak to Fosun, and the deal with BioNTech had not been “torn up”, only that it was “pending”.
BioNTech and Fosun did not immediately respond to a request for comment. China’s Taiwan Affairs Office declined immediate comment. China is currently observing the week-long Lunar New Year holiday.

block